Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000919574-19-003082
Filing Date
2019-05-01
Accepted
2019-05-01 12:06:22
Documents
1
Effectiveness Date
2019-05-01
Items
Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6256
  Complete submission text file 0000919574-19-003082.txt   7508
Mailing Address EUCLIDEAN TECHNOLOGIES GP, LLC 1325 AVENUE OF THE AMERICAS, 28TH FLOOR NEW YORK NY 10019
Business Address EUCLIDEAN TECHNOLOGIES GP, LLC 1325 AVENUE OF THE AMERICAS, 28TH FLOOR NEW YORK NY 10019 646-571-1670
Euclidean Fund For Cancer Research LP (Filer) CIK: 0001729236 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-311389 | Film No.: 19785794